6.23
-0.09(-1.42%)
Currency In USD
| Previous Close | 6.32 |
| Open | 6.19 |
| Day High | 6.75 |
| Day Low | 6.03 |
| 52-Week High | 27.5 |
| 52-Week Low | 4.03 |
| Volume | 47,019 |
| Average Volume | 2.4M |
| Market Cap | 4.02M |
| PE | -0.38 |
| EPS | -16.5 |
| Moving Average 50 Days | 8.61 |
| Moving Average 200 Days | 12.62 |
| Change | -0.09 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $2.35 as of February 07, 2026 at a share price of $6.23. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 5 years ago, it would be worth $3.25 as of February 07, 2026 at a share price of $6.23.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year
GlobeNewswire Inc.
Feb 05, 2026 1:30 PM GMT
Expected record fiscal second quarter revenue increase driven by expanding customer base and strong growth across all product categories Reader sales expected to post year-over-year growth of more than 100% in fiscal Q2, expanding installed base to d
Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market
GlobeNewswire Inc.
Jan 28, 2026 1:30 PM GMT
Clinical studies designed to support FDA clearance and planned commercial launch into the world’s largest drug screening market Company anticipates full data analysis by the end of March 2026; data to be incorporated into FDA 510(k) submission packa
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Jan 02, 2026 10:00 PM GMT
NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its prev